Related Experiment Video
Updated: Apr 14, 2026
09:30
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
4.7K
Quality control: can compounding pharmacy learn from the automotive industry?
International Journal of Pharmaceutical Compounding
|April 25, 2015
Summary
Compounding pharmacy, a specialized area, shows promise for improving healthcare efficiency and effectiveness. Despite overall declines in U.S. healthcare quality, this niche offers a model for success.
Area of Science:
- Healthcare System Analysis
- Pharmaceutical Compounding
- Quality Improvement in Healthcare
Background:
- The U.S. healthcare system faces challenges impacting future patient care quality.
- Major system changes often raise concerns about their long-term effects.
- Pharmaceutical compounding represents a specific, often overlooked, segment of healthcare.
Purpose of the Study:
- To examine the potential of pharmaceutical compounding as a model for improving healthcare.
- To identify opportunities within compounding pharmacy to enhance efficiency and effectiveness.
- To assess the role of compounding pharmacy in addressing broader healthcare quality concerns.
Main Methods:
- Qualitative analysis of the current healthcare landscape.
- Focus on the specific practices and outcomes within pharmaceutical compounding.
- Comparative assessment of compounding pharmacy's potential against general healthcare trends.
Main Results:
- The overall quality of the American healthcare system is perceived to have declined.
- Compounding pharmacy, despite its niche status, demonstrates functional successes.
- Significant opportunities exist within compounding pharmacy to boost healthcare efficiency.
Conclusions:
- Compounding pharmacy can serve as a positive role model for the wider healthcare system.
- This specialized field offers substantial potential for improving healthcare effectiveness.
- Targeted improvements in compounding pharmacy can lead to broader healthcare gains.
Related Concept Videos
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
228
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
228
01:05Quality Control
4.3K
Quality control is one of the three cyclical quality assurance activities that help keep a system under statistical control. Typical quality control activities include creating quality control charts, conducting proficiency testing, and documenting and archiving results.
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
4.3K
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
224
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
224
01:26Pharmaceutical Equivalents
267
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
267
01:19Quality Assurance
4.0K
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
4.0K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
285
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
285